ITI News Archive
Stanford Medicine News
Safer gene therapy?
A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.
Technique for quickly spotting TB
A newly created two-piece fluorescent probe gets activated when it comes in contact with tuberculosis bacteria in a phlegm.
Gut molecule protects against Salmonella
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.
Team seeks to decipher vulnerability to virus
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
Nicotine-mimicking molecules as medicine?
Stanford researchers discovered that a receptor that binds to nicotine and to clusters of beta-amyloid molecules is found on certain types of immune cells that can act as suppressors and regulators of the immune system.
One liver donor benefits two patients
Noah Hernandez, born in 2017, and James Howell, born in 1955, each benefited from a single liver to treat their life-threatening conditions.
Biomarker for flu susceptibility discovered
Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Cellular ‘death code’ discovered
Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.
Special diet helps bacteria engraft in gut
Gut bacteria able to digest seaweed can outcompete native bacteria in the large intestine of nori-fed mice, according to Stanford scientists. Favoring one species over others in the gut could help advance precision health.
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.